Biosimilars got the cold shoulder from health plans on preferred coverage

Biosimilars got the cold shoulder from health plans on preferred coverage

STAT Plus: Biosimilars got the cold shoulder from health plans when it came to preferred coverage

By ED SILVERMAN

JEAN-CHRISTOPHE VERHAEGEN/AFP/GETTY IMAGES

“If health plans don’t prioritize coverage for biosimilars, then utilization will never grow," said James Chambers, a Tufts University associate professor.

READ MORE